Skip to content

Study to Determine if Gloving in Addition to Hand Hygiene Will Prevent Invasive Infections and Necrotizing Enterocolitis

Gloving and Handwashing to Prevent Invasive Infections in Necrotizing Enterocolitis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01729000
Enrollment
124
Registered
2012-11-20
Start date
2008-10-31
Completion date
2011-06-30
Last updated
2012-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Infection, Neonatal Necrotizing Enterocolitis

Keywords

prematurity, infection control, necrotizing entercolitis

Brief summary

The purpose of this study is to compare the additional use of gloves (with handwashing before and after gloving) for all patient contact while infants have intravenous (central or peripheral) access in a RCT. Preterm infants \<1000 grams or less than 29 weeks gestational age will be randomized after birth to either a handwashing-gloving group or handwashing only group. The primary outcome will be the incidence of invasive infections (bacterial or fungal) or necrotizing enterocolitis. Secondary outcomes will include hospital days, preterm morbidities, mortality, and hospital costs.

Detailed description

All infants who had a birth weight of less than or equal to 1000 grams or who were born less than 29 weeks gestation were eligible for this study. 120 subjects were randomized by day of life(dol) 8 to one of two study groups--hand hygiene or hand hygiene plus gloving. Study signs were placed at the bedside and on the isolette sides of each infant with the appropriate study group guidelines. The investigators goal was to target the time period these infants are at high-risk for infection or NEC and its associated mortality. The targeted time was the first 4 weeks of life or longer while intravenous access is still required. The average age for the first episode of late-onset sepsis is 22(+/-0.5) days (median: 17 days; 75th percentile: 28 days; 95th percentile: 57 days). The majority of infections that occur after 4 weeks of life are in patients still requiring IV access (peripheral or central). The presence of an intravenous line in this group of preterm infants correlates with the presence of risk factors for infection that would necessitate the need for intravenous access including: parenteral nutrition, lipid infusion, use of broad spectrum antibiotics, and the intravenous line itself (if it is a central venous catheter). This strategy focused on the individual infant's risks, limits exposure to and decreases cost of intervention.

Interventions

OTHERGloves

All staff must wear gloves for subjects that are in the experimental group.

Sponsors

University of Virginia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 8 Days
Healthy volunteers
No

Inclusion criteria

* Birth weight \<1000 grams or gestational age ≤28 weeks * less than or equal to 7 days of age

Exclusion criteria

* greater than 7 days of age

Design outcomes

Primary

MeasureTime frameDescription
Invasive InfectionParticipants will be followed during their NICU hospitalization, an expected average of 3 monthsInvasive infection will be defined as growth of bacteria from culture (blood, urine, CSF, peritoneal) with clinical signs and symptoms of sepsis
Necrotizing enterocolitis (NEC)Participants will be followed for their entire NICU hospitalization, which is an average of 3 monthsNEC will be defined as stage II or greater using Bell's modified criteria

Secondary

MeasureTime frameDescription
Length of stayParticipants will be followed for their entire NICU hospitalization, which is an average of 3 monthsLength of stay will be compared in each study arm
MortalityParticipants will be followed for their entire NICU hospitalization, which is an average of 3 monthsMortality will be compared in each study arm
Hospital costParticipants will be followed for their entire NICU hospitalization, which is an average of 3 monthsHospital costs will be compared in each study arm
Common neonatal morbiditiesParticipants will be followed for their entire NICU hospitalization, which is an average of 3 monthsCommon morbidities will be compared in each study arm

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026